{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T19:56:43Z","timestamp":1785787003971,"version":"3.56.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2003,4,15]]},"DOI":"10.1097\/01.tp.0000056168.79903.20","type":"journal-article","created":{"date-parts":[[2003,12,2]],"date-time":"2003-12-02T06:40:08Z","timestamp":1070347208000},"page":"1020-1025","source":"Crossref","is-referenced-by-count":41,"title":["The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: a long-term analysis1"],"prefix":"10.1097","volume":"75","author":[{"given":"Ashok","family":"Jain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Mazariegos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renu","family":"Pokharna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Parizhskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randeep","family":"Kashyap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverly","family":"Kosmach-Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Fung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Reyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-19-20210129","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0889-8553(21)00075-3","article-title":"Chronic rejection of the liver allograft","volume":"22","author":"Lowes","year":"1993","journal-title":"Gastroenterol Clin North Am"},{"key":"R2-19-20210129","first-page":"1415","article-title":"Reversible vanishing bile duct syndrome after liver transplantation: report of 6 cases","volume":"23","author":"Hubscher","year":"1991","journal-title":"Transplant Proc"},{"key":"R3-19-20210129","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1600-065X.1993.tb00639.x","article-title":"Chronic allograft rejection","volume":"134","author":"Hayry","year":"1993","journal-title":"Immunol Rev"},{"key":"R4-19-20210129","first-page":"1442","article-title":"Recurrence of ductopenic rejection in liver allografts after retransplantation for vanishing bile duct syndrome","volume":"23","author":"van Hoek","year":"1991","journal-title":"Transplant Proc"},{"key":"R5-19-20210129","first-page":"3005","article-title":"FK 506 used as rescue therapy for human liver allograft recipients","volume":"23","author":"Demetris","year":"1991","journal-title":"Transplant Proc"},{"key":"R6-19-20210129","first-page":"14","article-title":"Conversion of liver allograft recipients from cyclosporine to FK 506-based immunosuppression: benefits and pitfalls","volume":"23","author":"Fung","year":"1991","journal-title":"Transplant Proc"},{"key":"R7-19-20210129","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/00007890-199707270-00014","article-title":"Efficacy of tacrolimus as rescue therapy for chronic rejection in orthotopic liver transplantation: a report of the U. S. Multicenter Liver Study Group","volume":"64","author":"Sher","year":"1997","journal-title":"Transplantation"},{"key":"R8-19-20210129","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1097\/00007890-200006270-00017","article-title":"Long-term results after conversion from cyclosporine to tacrolimus in pediatric liver transplantation for acute and chronic rejection","volume":"69","author":"Reyes","year":"2000","journal-title":"Transplantation"},{"key":"R9-19-20210129","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1053\/jlts.2001.25364","article-title":"Does tacrolimus offer virtual freedom from chronic rejection after primary liver transplantation? Risk and prognostic factors in 1,048 liver transplantations with a mean follow-up of 6 years","volume":"7","author":"Jain","year":"2001","journal-title":"Liver Transpl"},{"key":"R10-19-20210129","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1097\/00007890-200203270-00020","article-title":"Pediatric liver transplantation: a single center experience spanning 20 years","volume":"73","author":"Jain","year":"2002","journal-title":"Transplantation"},{"key":"R11-19-20210129","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/00007890-200008270-00015","article-title":"Comparative long-term evaluation of tacrolimus and cyclosporine in pediatric liver transplantation","volume":"70","author":"Jain","year":"2000","journal-title":"Transplantation"},{"key":"R12-19-20210129","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/hep.510310337","article-title":"Update of the International Banff Schema for Liver Allograft Rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. An International Panel","volume":"31","author":"Demetris","year":"2000","journal-title":"Hepatology"},{"key":"R13-19-20210129","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/lt.500050519","article-title":"Evolving concepts in the diagnosis, pathogenesis, and treatment of chronic hepatic allograft rejection","volume":"5","author":"Wiesner","year":"1999","journal-title":"Liver Transpl Surg"},{"key":"R14-19-20210129","first-page":"1403","article-title":"Combination immunosuppression with azathioprine reduces the incidence of ductopenic rejection and vanishing bile duct syndrome after liver transplantation","volume":"23","author":"van Hoek","year":"1991","journal-title":"Transplant Proc"},{"key":"R15-19-20210129","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1097\/00007890-199205000-00017","article-title":"Conversion of liver allograft recipients from cyclosporine to FK506 immunosuppressive therapy: a clinicopathologic study of 96 patients","volume":"53","author":"Demetris","year":"1992","journal-title":"Transplantation"},{"key":"R16-19-20210129","first-page":"1206","article-title":"Posttransplant B, non-A non-B, and cytomegalovirus hepatitis increase the risk of developing chronic rejection after liver transplantation","volume":"27","author":"Bronsther","year":"1995","journal-title":"Transplant Proc"},{"key":"R17-19-20210129","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1097\/00007890-199305000-00024","article-title":"The influence of HLA matching on cytomegalovirus hepatitis and chronic rejection after liver transplantation","volume":"55","author":"Manez","year":"1993","journal-title":"Transplantation"},{"key":"R18-19-20210129","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S0041-1345(96)00254-0","article-title":"Causes of graft loss following liver transplantation for chronic hepatitis C","volume":"29","author":"O\u2019Reilly","year":"1997","journal-title":"Transplant Proc"},{"key":"R19-19-20210129","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0140-6736(88)92356-2","article-title":"Cytomegalovirus infection and donor\/recipient HLA antigens: interdependent co-factors in pathogenesis of vanishing bile-duct syndrome after liver transplantation","volume":"2","author":"O\u2019Grady","year":"1988","journal-title":"Lancet"},{"key":"R20-19-20210129","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/00000658-200010000-00004","article-title":"Long-term survival after liver transplantation in 4,000 consecutive patients at a single center","volume":"232","author":"Jain","year":"2000","journal-title":"Ann Surg"},{"issue":"8920","key":"R21-19-20210129","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0140-6736(94)91766-3","article-title":"Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection. European FK506 Multicentre Liver Study Group see comments.","volume":"344","year":"1994","journal-title":"Lancet"},{"issue":"17","key":"R22-19-20210129","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1056\/NEJM199410273311702","article-title":"A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation. The U. S. Multicenter FK506 Liver Study Group see comments.","volume":"331","year":"1994","journal-title":"N Engl J Med"},{"key":"R23-19-20210129","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/00005176-199801000-00016","article-title":"The use of tacrolimus in pediatric liver transplantation","volume":"26","author":"McDiarmid","year":"1998","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R24-19-20210129","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1034\/j.1399-3046.1999.00002.x","article-title":"Long-term outcomes in pediatric liver recipients: comparison between cyclosporin A and tacrolimus","volume":"3","author":"Cao","year":"1999","journal-title":"Pediatr Transplant"},{"key":"R25-19-20210129","first-page":"619","article-title":"Two-year experience with FK 506 in pediatric patients","volume":"25","author":"Tzakis","year":"1993","journal-title":"Transplant Proc"},{"key":"R26-19-20210129","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1034\/j.1399-3046.2001.005002093.x","article-title":"Reasons why some children receiving tacrolimus therapy require steroids more than 5 years post liver transplantation","volume":"5","author":"Jain","year":"2001","journal-title":"Pediatr Transplant"},{"key":"R27-19-20210129","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1128\/IAI.40.1.172-176.1983","article-title":"Human interferon-gamma enhances the expression of class I and class II major histocompatibility complex products in neoplastic cells more effectively than interferon-alpha and interferon-beta","volume":"40","author":"Dolei","year":"1983","journal-title":"Infect Immun"},{"key":"R28-19-20210129","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/S0140-6736(84)92327-4","article-title":"Recombinant leucocyte interferon A induces steroid-resistant acute vascular rejection episodes in renal transplant recipients","volume":"1","author":"Kramer","year":"1984","journal-title":"Lancet"},{"key":"R29-19-20210129","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/lt.500040315","article-title":"Incidence and severity of acute allograft rejection in liver transplant recipients treated with alpha interferon","volume":"4","author":"Jain","year":"1998","journal-title":"Liver Transplant Surg"},{"key":"R30-19-20210129","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1056\/NEJM199404213301618","article-title":"Acute vanishing bile duct syndrome after interferon therapy for recurrent HCV infection in liver-transplant recipients","volume":"330","author":"Dousset","year":"1994","journal-title":"N Engl J Med"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/01.TP.0000056168.79903.20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T19:03:03Z","timestamp":1785783783000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007890-200304150-00019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,4,15]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2003]]}},"URL":"https:\/\/doi.org\/10.1097\/01.tp.0000056168.79903.20","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2003,4,15]]}}}